Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Beyond Eosinophils: Proteomics to Identify Potential Biomarkers of Organ Damage and Response to MEPOLIZUMAB in EGPA

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07343661
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:37.541385+00:00
Published At
2026-01-15T00:00:00+00:00
Record Updated At
2026-01-15
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["EGPA - Eosinophilic Granulomatosis With Polyangiitis", "Severe Asthma", "Eosinophilic Asthma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-01-15"
protocolSection.identificationModule.nctId
"NCT07343661"
protocolSection.identificationModule.officialTitle
"Beyond Eosinophils: Proteomics to Identify Potential Biomarkers of Organ Damage and Response to MEPOLIZUMAB in EGPA"
protocolSection.statusModule.overallStatus
"ENROLLING_BY_INVITATION"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • EGPA - Eosinophilic Granulomatosis With Polyangiitis (protocolSection.conditionsModule.conditions)
  • Severe Asthma (protocolSection.conditionsModule.conditions)
  • Eosinophilic Asthma (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.